Verastem | VSTM - Loan Capital

Stock Price
5.82
Daily Change
-0.02 -0.34%
Monthly
-14.29%
Yearly
-2.51%
Q1 Forecast
5.64

Verastem reported $50.32M in Loan Capital for its fiscal quarter ending in March of 2024.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
AstraZeneca USD 26.14B 19.58B Dec/2025
Curis USD 29.43M 10.69M Jun/2024
Cytokinetics USD 158.75M 554.3M Sep/2025
Gilead Sciences USD 22.14B 5M Sep/2025
Incyte USD 35.37M 3.61M Sep/2025
Laboratory Of America USD 5.15B 3.9M Sep/2025
Novartis USD 24.24B 174M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025
TG Therapeutics USD 245.34M 303K Sep/2025
Verastem USD 50.32M 10.23M Mar/2024